Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Overexpression of MCM10 promotes cell proliferation and predicts poor prognosis in prostate cancer

10 Aug 2018

Abstract excerpt

BACKGROUND: Prostate cancer (PCa) is one of the most malignant tumors of the male urogenital system. There is an urgent need to identify novel biomarkers for PCa. METHODS: In this study, we evaluated the expression levels of MCM10 in prostate cancer by analyzing public datasets (including The Cancer Genome Atlas and GSE21032). Furthermore, loss of function assays was performed to evaluate the effects of MCM10 on...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ferroptosis and cancer prognosis
Share to Prostate Cancer Diagnosis and Treatment
Share to Prostate Cancer Treatment and Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30095171
DOI: 10.1002/pros.23703

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Overexpression of MCM10 promotes cell proliferation and predicts poor prognosis in prostate cancerPMID 30095171Read ↗

MCM7 amplification and overexpression are associated with prostate cancer progressionSemantic proximity Read ↗

Diagnosis of prostate cancer by detection of minichromosome maintenance 5 protein in urine sedimentsSemantic proximity Read ↗

MCM2-7 complex is a novel druggable target for neuroendocrine prostate cancerSemantic proximity Read ↗

Elevated expression of PCGEM1, a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patientsSemantic proximity Read ↗

Multi-omics pan-cancer analyses identify MCM4 as a promising prognostic and diagnostic biomarkerSemantic proximity Read ↗

Multi-Omics Analysis of MCM2 as a Promising Biomarker in Pan-CancerSemantic proximity Read ↗

Overexpression of CDCA8 Predicts Poor Prognosis and Promotes Tumor Cell Growth in Prostate CancerSemantic proximity Read ↗

MCM10 : An effective treatment target and a prognostic biomarker in patients with uterine corpus endometrial carcinomaSemantic proximity Read ↗

Overexpression of AR‐regulated lncRNA TMPO‐AS1 correlates with tumor progression and poor prognosis in prostate cancerSemantic proximity Read ↗

DNA Replication Licensing Protein MCM10 Promotes Tumor Progression and Is a Novel Prognostic Biomarker and Potential Therapeutic Target in Breast CancerSemantic proximity Read ↗

Inhibition of N-Acetyltransferase 10 Suppresses the Progression of Prostate Cancer through Regulation of DNA ReplicationSemantic proximity Read ↗

Tumor suppressor role of RBM22 in prostate cancer acting as a dual-factor regulating alternative splicing and transcription of key oncogenic genesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.